Principales conclusions et analyse des parts de marché du séquençage de nouvelle génération (NGS) en oncologie clinique d'ici 2025-2031
Clinical Oncology Next Generation Sequencing (NGS) Market Report Analysis
Clinical Oncology Next Generation Sequencing (NGS) Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Agilent Technologies, Inc.
- Caris Life Sciences
- F. Hoffmann-La Roche Ltd
- FOUNDATION MEDICINE, INC.
- Illumina, Inc.
- Myriad Genetics, Inc.
- Oxford Nanopore Technologies
- PerkinElmer Inc
- QIAGEN
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Technologie
- séquençage de l'exome entier
- séquençage du génome entier
- séquençage ciblé et reséquençage
By Flux de travail
- analyse des données NGS
- pré-séquençage NGS
- séquençage NGS
By Application
- diagnostics compagnon
- dépistage
- autres applications
By Utilisateur final
- hôpitaux et cliniques
- laboratoires
Get Free Sample For